Today, we had the first direct link between the problems in Theranos’ labs and Elizabeth Holmes. Former manager of assay systems Surekha Gangakhedkar’s job was preparing blood tests for use in patients. The system was unreliable; describing herself as “stressed and unhappy and concerned with the way the launch was going,” Gangakhedkar quit.
Gangakhedkar met with Holmes to explain why she was resigning: she didn’t think the Edisons were good enough for patient use. Holmes told her Theranos had “promised to deliver to the customers and didn’t have much of a choice,” except to go ahead with the launch, Gangakhedkar testified.
Holmes, who is standing trial for wire fraud and conspiracy to commit wire fraud, hadn’t been directly linked to lab inadequacies in the testimony from the two previous witnesses. But Holmes was hands-on when it came to the R&D lab, even emailing Gangakhedkar at 1AM to ask how the validation testing was going.